Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Open accessThe DOI matches its Crossref record; 235 of the 239 references it cites were found in a registry or an index.
Abstract
These guidelines were formulated to assist physicians and other health care professionals with various aspects of the administration of outpatient parenteral antimicrobial therapy (OPAT). Although there are many reassuring retrospective studies on the efficacy and safety of OPAT, few prospective studies have been conducted to compare the risks and outcomes for patients who receive treatment as outpatients rather than as inpatients. Because truly evidence-based studies are lacking, the present guidelines are formulated from the collective experience of the committee members and advisors from related organizations. Important aspects of OPAT are described in the text and tables and include the following: The literature supports the effectiveness of OPAT for a wide variety of infections (table 1 and the Appendix). Infections treated with outpatient parenteral antimicrobial therapy (OPAT) and the antibiotics used in 4 studies or sites. A thorough assessment of the patient's general medical condition, the infectious process, and the home situation is necessary before starting therapy (table 2) Specific considerations in evaluating patients for outpatient parenteral antimicrobial therapy (OPAT). Prescribing physicians should be aware of a number of aspects of OPAT which distinguish it from other forms of therapy. These include the required teamwork, communication, monitoring, and outcome measurements (tables 3 and 4). Key elements required for an outpatient parenteral antimicrobial therapy (OPAT) program. Key elements required for evaluating an outpatient parenteral antimicrobial therapy (OPAT) program when the patient is to be referred. The physician has a unique role on the OPAT team, which may also include nursing, pharmacy, and social services. These responsibilities include establishing a diagnosis, prescribing treatment, determining the appropriate site of care, monitoring during therapy, and assuring the overall quality of care. Antimicrobial selection for OPAT is different from that for therapy in the hospital. Once-daily drug administration has many advantages. Potential for adverse effects and the stability of an antimicrobial once it is mixed must be considered (tables 5–7). Properties of commonly prescribed antimicrobials at various temperatures. Suggestions for laboratory parameters that should be monitored weekly during outpatient parenteral antimicrobial therapy (OPAT). The importance of administering the first dose of an antibiotic in a supervised setting is emphasized. Regular clinical and laboratory monitoring of patients receiving OPAT is essential and varies with the antimicrobial chosen (table 8). Outcome measures for outpatient parenteral antimicrobial therapy (OPAT). Outcomes measures should be an integral part of any OPAT program, to assure the effectiveness and quality of care (table 9). Internet resources with information on outpatient parenteral antimicrobial therapy (OPAT). Children receiving OPAT must be considered differently because of their special needs. The practice of administering intravenous antimicrobial therapy in the home and in alternate care settings has grown rapidly since it was first described in 1974 by Rucker and Harrison [1]. The most common infections treated and antimicrobials used by a variety of programs are shown in table 1. In the United States, OPAT is estimated to be a multibillion-dollar-a-year industry and is provided to 1 in 1000 Americans each year [10]. The growth of OPAT has been fueled by a variety of factors including the push for cost containment, the development of antimicrobial agents that can be administered once daily, technological advances in vascular access and infusion devices, increased acceptance of such therapy by both patients and health care personnel, and the availability of reliable and skilled services for OPAT in the community. Although OPAT has become widely accepted as a form of medical therapy (see Appendix), more information is needed regarding its benefits, safety, and limitations. This is especially true with the economic incentives for early discharge that exist for payors. These guidelines update those written in 1997 [11] and are intended to ensure successful implementation of parenteral antimicrobial services for patients in varied community settings, including the home and outpatient facilities, such as physicians' offices, hospital clinics, ambulatory-care centers, day hospitals, and skilled nursing facilities. They have been formulated to incorporate the perspectives of the team of physicians, nurses, pharmacists and other health care professionals necessary for an effective and safe program [6, 8, 12]. Advice and participation were requested of the leading infusion-nurse, pharmacy, and to a on the The were formulated from the collective clinical experience of the of and from the organizations. In the of the and quality of in of OPAT is by a of prospective studies and a number of are The information can a for programs to
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Outpatient parenteral antibiotic therapy (OPAT) is efficacious, safe, and cost-effective for a variety of infections, [323][324][325] including IE that requires prolonged parenteral therapy in hospitalized patients who otherwise no longer require inpatient care but do require continued parenteral antimicrobial therapy.”
Citations
Cites
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Medication Errors and Adverse Drug Events in Pediatric Inpatients
Kaushal, R. (2001) · JAMA · doi:10.1001/jama.285.16.2114 · Cited by 1,917
Guidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Guidelines for the prevention of intravascular catheter-related infections
da Silva, G. D., de Almeida, V. S., Querido, D. L., Esteves, A. P. V. D. S., dos Santos, J. P. O., & Rezende, T. F. (2012) · doi:10.5205/3705 · Cited by 1,119
Niederman, M. S., Bass, J. B., Campbell, G. D., Fein, A. M., Grossman, R. F., Mandell, L. A., Marrie, T. J., Sarosi, G. A., Torres, A., & Yu, V. L. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1418 · Cited by 1,045
(2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018
Quality of Care, Process, and Outcomes in Elderly Patients With Pneumonia
Meehan, T. P. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550230056037 · Cited by 919
Research works printed but not linked: 28
- Winters, 1992, Home infusion therapy: a service and demographic profile: a report for the National Alliance for Infusion Therapy, 1
- Hankwitz, 1994, The expanding and increasingly important role of the home health care agency medical director, Am Ac Home Care Phys Newsletter, 6, 8
- Tice, 1993, Growing pains in outpatient intravenous antibiotic therapy, Infect Dis Clin Pract, 1, 74
- 1986, Wickline v State of California, 228 Cal. Rptr. 661, 192. Cap. App. 3d 1630
- 1981, Physicians, surgeons and other healers. American Jurisprudence, 226
- Tice, 1997, Delivery models for outpatient parenteral antimicrobial therapy. In: Outpatient parenteral antimicrobial therapy: current status, 7
- Residency Review Committee, Specific program content. CAAR Program Information from Workshop for Internal Medicine Subspecialty Residencies in Infectious Disease. 11. 2001. American Board of Internal Medicine. Ref Type: Conference Proceeding.
- Lonsway, 2001, Intravenous therapy in the home, 501
- Mortlock, 2001, Intravenous therapy in the alternative care setting, 535
- Skokal, 2000, IV push at home?, RN, 63, 26
- Tice, 2002, Adverse effects with intravenous antibiotics with OPAT
- Rehm, 2000, Rates of adverse events associated with community-based parenteral anti-infective therapy, J Clin Outcomes Manage, 7, 23
- Martinelli, 1988, Aminoglycoside questionnaire results
- Hautekeete, 1995, Hepatotoxicity of antibitoics, Acta Gastroenterol Belg, 58, 290
- 1999, 2000–2001 Comprehensive accreditation manual for ambulatory care
- Barrell, 1998, ORYX: outcomes measurement and accreditation, Infusion, May, 37
- Poole, 1998, Outcomes measurements: making sense of the data, Infusion, May, 25
- Tice, 2000, Documenting the value of OPAT: outcomes studies and patient registries, Can J Infect Dis, 10, 45
- Tice, 2000, Outcomes registry for outpatient IV antimicrobial therapy, Infusion, May, 27
- Outpatient Parenteral Antimicrobial Therpay Outcomes Registry Web site
- Tice, 2003, Reasons for failures with OPAT [abstract 293]
- Arditi, 1990, Convalescent outpatient therapy for selected children with acute bacterial meningitis, Semin Pediatr Infect Dis, 1, 404
- Sudela, 1990, Nursing aspects of pediatric home infusion therapy for the treatment of serious, Semin Pediatr Infect Dis, 1, 306
- Tice, 2003, OPAT outcomes registry evaluaton of diabetic extremity infections [abstract 291]
- Wai, 1999, A cost analysis of an outpatient parenteral antibiotic program (OPAT): a Canadian teaching hospital and ministry of health perspective, 133
- Tice, 1997, Osteomyelitis
- Rehm, 1992, Home intravenous antibiotic therapy (HIVAT) for endocarditis
- Gentry, 1989, New approches to the diagnosis and treatment of infective endocarditis, Texas Heart Institute J, 16, 250
Cited by
Items 201–300 of 575
Knackstedt, E. D., Stockmann, C. R., Davis, C. R., Thorell, E. A., Pavia, A. T., & Hersh, A. L. (2014) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2014.27 · Cited by 27
Norton, K., Ingram, P. R., Heath, C. H., & Manning, L. A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt402 · Cited by 27
Outpatient parenteral antibiotic therapy (OPAT) in Asia: missing an opportunity
Fisher, D. A., Michaels, J., Hase, R., Zhang, J., Kataria, S., Sim, B. L. H., Tsang, J. K.-Y., Pollard, J., Chan, M., & Swaminathan, S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw551 · Cited by 27
Gordon, S. M., Shrestha, N. K. M., & Rehm, S. J. (2011) · Journal of Hospital Medicine · doi:10.1002/jhm.867 · Cited by 27
Self-citationChanges in Antimicrobial Use Prevalence in China: Results from Five Point Prevalence Studies
Li, C., Ren, N., Wen, X., Zhou, P., Huang, X., Gong, R., Lv, Y., Feng, L., Wu, H., Liu, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082785 · Cited by 27
Bianchini, M. L., Kenney, R. M., Lentz, R., Zervos, M. J., Malhotra, M., & Davis, S. L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1076 · Cited by 26
Gramlich, Y., Klug, A., Walter, G., Kremer, M., Hoffmann, R. F. G., & Kemmerer, M. (2019) · Surgical Infections · doi:10.1089/sur.2019.245 · Cited by 26
Bouji, N., Wen, S., & Dietz, M. J. (2022) · Journal of Bone and Joint Infection · doi:10.5194/jbji-7-191-2022 · Cited by 26
Mujal, A., Sola, J., Hernandez, M., Villarino, M.-A., Machado, M. L., Baylina, M., Taján, J., & Oristrell, J. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2330-0 · Cited by 26
Marschang, S., & Bernardo, G. (2015) · Journal of Hospital Infection · doi:10.1016/j.jhin.2015.01.017 · Cited by 26
Winans, S. A., Luce, A. M., & Hasbun, R. (2013) · Infection · doi:10.1007/s15010-013-0477-0 · Cited by 26
Muldoon, E. G., Allison, G. M., Gallagher, D., Snydman, D. R., & Bergin, C. J. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1899-4 · Cited by 26
de Oliveira, P. R. D., Félix, C. D. S., de Carvalho, V. C., Giovani, A. M. M., dos Reis, R. S., Beraldo, M., Albuquerque, E. P. R., Ferreira, W. C., Silva, J. D. S., & Lima, A. L. L. (2016) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2016.03.005 · Cited by 26
Polat, M., & Kara, S. S. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s148703 · Cited by 26
Durojaiye, O. C., Cartwright, K. E., & Ntziora, F. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.07.013 · Cited by 26
Gramlich, Y., Walter, G., Klug, A., Harbering, J., Kemmerer, M., & Hoffmann, R. F. G. (2018) · International Orthopaedics · doi:10.1007/s00264-018-4066-9 · Cited by 26
Wilke, M. H., Worf, K., Preisendörfer, B., Heinlein, W., Kast, T., & Bodmann, K. (2019) · GMS infectious diseases · doi:10.3205/id000043 · Cited by 26
Outpatient Parenteral Antibiotic Therapy in the Elderly: an Italian Observational Multicenter Study
Esposito, S., Leone, S., Noviello, S., Ianniello, F., Russo, M. C., Foti, G., Carpentieri, M. S., Cellesi, C., Zanelli, G., Cellini, A., et al. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.2.193 · Cited by 26
Roig, S. O., Mujal, A., Julve, M. D. C., González-Sánchez, A., Jiménez-Pérez, R., Hernández-Ávila, M., Alfonso, N. D., Maye-Pérez, I., Valle-Delmás, T., Rodríguez‐Sánchez, A., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11081124 · Cited by 25
Briquet, C., Cornu, O., Servais, V., Blasson, C., Vandeleene, B., Yıldız, H., Stainier, A., & Yombi, J. C. (2019) · Acta Clinica Belgica · doi:10.1080/17843286.2019.1608396 · Cited by 25
Congeni, B. L. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003631397 · Cited by 25
Tice, A. D., Turpin, R. S., Hoey, C. T., Lipsky, B. A., Wu, J., & Abramson, M. A. (2007) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/64.10.1080 · Cited by 25
Self-citationHome intravenous antibiotics in a tertiary care hospital in Saudi Arabia
Baharoon, S. A., Almodaimeg, H., Watban, H. A., Jahdali, H. A., Alenazi, T. H., Sayyari, A. A. A., Al‐Dawood, A., Al‐Sultan, M., & Alsafi, E. (2011) · Annals of Saudi Medicine · doi:10.4103/0256-4947.84621 · Cited by 24
Hensey, C. C., Sett, A., Connell, T. G., & Bryant, P. A. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001605 · Cited by 24
Recommendations for outpatient parenteral antimicrobial therapy in Brazil
de Oliveira, P. R. D., de Carvalho, V. C., Cimerman, S., & Lima, A. L. M. (2017) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2017.06.006 · Cited by 24
Hase, R., Yokoyama, Y., Suzuki, H., Uno, S., Mikawa, T., Suzuki, D., Muranaka, K., & Hosokawa, N. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.033 · Cited by 24
Blumenthal, K. G., Youngster, I., Shenoy, E. S., Banerji, A., & Nelson, S. B. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02504-13 · Cited by 24
Keyloun, K. R., Weber, D. J., Gardstein, B. M., Berger, A., Gillard, P. J., & Ganz, M. L. (2018) · Hospital Practice · doi:10.1080/21548331.2018.1506673 · Cited by 24
Townsend, J., Keller, S. C., Tibuakuu, M., Thakker, S. S., Webster, B., Siegel, M., Psoter, K. J., Mansour, O., & Perl, T. M. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy274 · Cited by 24
Akar, A., Singh, N. K., & Hyun, D. Y. (2013) · Clinical Pediatrics · doi:10.1177/0009922813507999 · Cited by 24
Chan, M., Ooi, C. K., Wong, J. G. X., Zhong, L., & Lye, D. C. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2569-4 · Cited by 23
Hamad, Y., Connor, L., Bailey, T. C., & George, I. A. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa341 · Cited by 23
de Beaubien, B. C., Belden, K. A., Bell, K., Boyle, K. K., Cordero‐Ampuero, J., Valle, C. J. D., Eijer, H., Ferry, C., Janz, V., Kessler, B., et al. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.09.033 · Cited by 23
O’Callaghan, K. P., Tapp, S., Hajkowicz, K. M., Legg, A., & McCarthy, K. L. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-03461-3 · Cited by 23
Altokhais, T. I., Al-Obaid, O. A., Kattan, A. E., Amer, Y. S., & Groups, C. C. (2016) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12658 · Cited by 22
Gramlich, Y., Hagebusch, P., Faul, P., Klug, A., Walter, G., & Hoffmann, R. F. G. (2019) · International Orthopaedics · doi:10.1007/s00264-019-04297-y · Cited by 22
Talan, D. A., Mower, W. R., LoVecchio, F., Rothman, R. E., Steele, M. T., Keyloun, K. R., Gillard, P. J., Copp, R., & Moran, G. J. (2021) · Academic Emergency Medicine · doi:10.1111/acem.14258 · Cited by 22
Galpérine, T., Ader, F., Piriou, P., Judet, T., Perronne, C., & Bernard, L. (2006) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2006.01.002 · Cited by 22
Alternative clinical indications for novel antibiotics licensed for skin and soft tissue infection?
Dryden, M. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000142 · Cited by 21
Banerjee, R., Beekmann, S. E., Doby, E. H., Polgreen, P. M., Rathore, M. H., & Hersh, A. L. (2013) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pis137 · Cited by 21
Ibrahim, L. F., Hopper, S. M., Connell, T. G., Daley, A. J., Bryant, P. A., & Babl, F. E. (2017) · Emergency Medicine Journal · doi:10.1136/emermed-2017-206829 · Cited by 21
Gramlich, Y., Steinkohl, D., Kremer, M., Kemmerer, M., Hoffmann, R. F. G., & Klug, A. (2021) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-021-03907-y · Cited by 21
Shrestha, N. K. M., Kim, S. L., Rehm, S. J., Everett, A. D., & Gordon, S. M. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky133 · Cited by 20
Self-citationTritt, A., Kay‐Rivest, E., Paradis, T., & Duval, M. (2019) · Clinical Otolaryngology · doi:10.1111/coa.13284 · Cited by 20
Hakim, A., Braun, H. M., Thornton, D., & Strymish, J. M. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.12.008 · Cited by 20
Nathwani, D., Eckmann, C., Lawson, W., Solem, C. T., Corman, S. L., Stephens, J., Macahilig, C. P., Simoneau, D., Chambers, R. B., Li, J. Z., et al. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-476 · Cited by 20
Tan, Y. E., Ng, L. S. Y., & Tan, T. Y. (2014) · Pathology · doi:10.1097/pat.0000000000000146 · Cited by 20
Revankar, N., Ward, A. J., Pelligra, C. G., Kongnakorn, T., Fan, W., & LaPensee, K. (2014) · Journal of Medical Economics · doi:10.3111/13696998.2014.941065 · Cited by 20
Outpatient parenteral antimicrobial therapy (OPAT) and the general physician
Barlow, G. D., Barr, D. A., & Seaton, R. (2013) · Clinical Medicine · doi:10.7861/clinmedicine.13-5-495 · Cited by 20
Gonzalez, M. F., Rubio, M. M., Mujal, A., Estrada, O., Pérez, D. F., Reinoso, L. S., Fabrellas, E. F., & Vives, E. C. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.13022 · Cited by 20
Stability of doripenem in polyvinyl chloride bags and elastomeric pumps
Crandon, J. L., Sutherland, C. A., & Nicolau, D. P. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp090429 · Cited by 20
Effectiveness of azithromycin in aspiration pneumonia: a prospective observational study
Marumo, S., Teranishi, T., Higami, Y., Koshimo, Y., Kiyokawa, H., & Kato, M. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0685-y · Cited by 19
Marculescu, C. E., Berbari, E. F., Cantey, J. R., & Osmon, D. R. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.11.005 · Cited by 19
Outcomes of Outpatient Parenteral Antimicrobial Therapy in Patients With Injection Drug Use
Vazirian, M., Jerry, J. M., Shrestha, N. K. M., & Gordon, S. M. (2018) · Psychosomatics · doi:10.1016/j.psym.2018.02.005 · Cited by 19
Patel, S. V., Burzio, V., Green, H. E., Rees, S., Tebruegge, M., Jones, C. E., & Faust, S. N. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002031 · Cited by 19
Lam, P. W., Volling, C., Chan, T., Wiggers, J. B., Castellani, L., Wright, J. K., Peckham, K., Shadowitz, S., Tasker, S., MacFadden, D. R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy301 · Cited by 19
Outpatient Antimicrobial Therapy for Infective Endocarditis is Safe
Rajaratnam, D., & Rajaratnam, R. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2020.08.016 · Cited by 19
Wu, K. H., Sakoulas, G., & Geriak, M. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab418 · Cited by 19
Treatment of MRSA infections in India: Clinical insights from a Delphi analysis
Singhal, T., Rodrigues, C. S., Soman, R. N., Wattal, C., Swaminathan, S., Nambi, S., Talwar, D., Singh, R. K., & Todi, S. K. (2021) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2021.11.005 · Cited by 19
Rae, N., Kenny, C. C., & Muldoon, E. G. (2018) · Mycoses · doi:10.1111/myc.12874 · Cited by 19
Durojaiye, O. C., Fiori, C., & Cartwright, K. E. (2025) · Antibiotics · doi:10.3390/antibiotics14050451 · Cited by 18
Prolonged intravenous instead of oral antibiotics for acute hematogenous osteomyelitis in children
Wood, J. B., & Johnson, D. (2016) · Journal of Hospital Medicine · doi:10.1002/jhm.2549 · Cited by 18
Frieler, S., Hanusrichter, Y., Bellova, P., Geßmann, J., Schildhauer, T. A., & Baecker, H. (2020) · Journal of Orthopaedic Research® · doi:10.1002/jor.24906 · Cited by 18
Non-specific spondylodiscitis: a new perspective for surgical treatment
Giampaolini, N., Berdini, M., Rotini, M., Palmisani, R., Specchia, N., & Martiniani, M. (2022) · European Spine Journal · doi:10.1007/s00586-021-07072-z · Cited by 18
Esposito, S., Leone, S., Petta, E., Noviello, S., & Ianniello, F. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70547-3 · Cited by 18
Outpatient management of pediatric acute mastoiditis
Alkhateeb, A., Morin, F., Aziz, H., Manogaran, M., Guertin, W., & Duval, M. (2017) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2017.09.008 · Cited by 18
Acute Hematogenous Bacterial Osteoarticular Infections in Children
Donaldson, N., Sanders, J., Child, J., & Parker, S. K. (2020) · Pediatrics in Review · doi:10.1542/pir.2018-0201 · Cited by 18
Tice, A. D., & Rehm, S. J. (2010) · Clinical Infectious Diseases · doi:10.1086/653517 · Cited by 18
Self-citationJensen, I. S., Wu, E., Fan, W., Lodise, T. P., Nicolau, D. P., Dufour, S., Cyr, P. L., & Sulham, K. A. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.22.6.752 · Cited by 18
Tratamiento antimicrobiano intravenoso en el domicilio
Ramallo, V. J. G., & Santiago, E. B. (2008) · Medicina Clínica · doi:10.1016/s0025-7753(08)72262-0 · Cited by 18
Outpatient treatment of osteomyelitis with telavancin
Schroeder, C. P., Anglen, L. J. V., Dretler, R. H., Adams, J. S., Prokesch, R. C., Luu, Q., & Krinsky, A. H. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.01.034 · Cited by 17
Bella, S. D., Beovič, B., Fabbiani, M., Valentini, M., & Luzzati, R. (2020) · Antibiotics · doi:10.3390/antibiotics9070398 · Cited by 17
Ravelingien, T., Buyle, F. M., Deryckere, S., Sermijn, E., Debrauwere, M., Verplancke, K., Callens, S. F. J., Commeyne, S., Pattyn, C., & Vogelaers, D. (2016) · Acta Clinica Belgica · doi:10.1080/17843286.2016.1183285 · Cited by 17
Psaltikidis, E. M., da Silva, E. N., Moretti, M. L., Trabasso, P., Stucchi, R. S. B., Aoki, F. H., Cardoso, L. G. D. O., Höfling, C. C., Bachur, L. F., Ponchet, D. D. F., et al. (2018) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2019.1541404 · Cited by 17
Britt, R. S., LaSalvia, M. T., Padival, S., Patel, P., McCoy, C. P., & Mahoney, M. V. G. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz496 · Cited by 17
Outpatient Antimicrobial Treatment for People Who Inject Drugs
Hurley, H., Sikka, M. K., Jenkins, T. C., Cari, E. V., & Thornton, A. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.06.009 · Cited by 17
Pediatric Outpatient Parenteral Antimicrobial Therapy: An Update
Maraqa, N., & Rathore, M. H. (2010) · Advances in Pediatrics · doi:10.1016/j.yapd.2010.09.002 · Cited by 17
Lee, S., Park, H., Choi, J.-H., & Huh, J. (2013) · Journal of Cerebrovascular and Endovascular Neurosurgery · doi:10.7461/jcen.2013.15.3.235 · Cited by 17
Connors, W. J. A., Rabie, H., Figueiredo, R. L. F., Holton, D., & Parkins, M. D. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2303-2 · Cited by 16
Bradley, J. S., & Sauberan, J. B. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00294-4 · Cited by 16
Self-citationHazen, A., Pizzicato, L. N., Hom, J. K., Johnson, C. C., & Viner, K. M. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108465 · Cited by 16
Wen, W., Li, H., Wang, C., Chen, C., Tang, J., Zhou, M., Hong, X., Cheng, Y., Wu, Q., Zhang, X., et al. (2022) · Revista Española de Quimioterapia · doi:10.37201/req/011.2022 · Cited by 16
Dalbavancin as a cost effective antibiotic
Nair, T., Fitzgerald, J., Ly, B., & Wallace, M. R. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1365169 · Cited by 16
Evaluation of OPAT in the Age of Antimicrobial Stewardship
Mahoney, M. V. G., Ryan, K. L., & Alexander, B. T. (2020) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-020-00217-6 · Cited by 16
National Trends of Acute Osteomyelitis and Peripherally Inserted Central Catheters in Children
Shaikh, N., Umscheid, J., Rizvi, S., Bhatt, P. J., Vasudeva, R., Yagnik, P. J., Bhatt, N. S., Donda, K., & Dapaah-Siakwan, F. M. (2021) · Hospital Pediatrics · doi:10.1542/hpeds.2020-005794 · Cited by 16
Pence, L. M., Mock, C., Kays, M. B., Damer, K. M., Muloma, E., & Erdman, S. M. (2014) · Diabetic Medicine · doi:10.1111/dme.12501 · Cited by 16
Wong, K. K., Fraser, T. G., Shrestha, N. K. M., Fatica, C. A., & Deshpande, A. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2014.6 · Cited by 16
Werth, B. J., Carreno, J. J., & Reveles, K. R. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.01.028 · Cited by 16
Mohammed, S. A., Cotta, M. O., Assefa, G. M., Erku, D., & Sime, F. B. (2024) · Journal of Hospital Infection · doi:10.1016/j.jhin.2024.02.006 · Cited by 15
Mohammed, S. A., Roberts, J. A., Mirón-Rubio, M., López-Cortés, L. E., Assefa, G. M., Pollard, J., McCarthy, K. L., Gilchrist, M. J., Cotta, M. O., & Sime, F. B. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf049 · Cited by 15
Impact of expanding a paediatric OPAT programme with an antimicrobial stewardship intervention
Huynh, J., Hodgson, K. A., Boyce, S., Ibrahim, L. F., & Bryant, P. A. (2020) · Archives of Disease in Childhood · doi:10.1136/archdischild-2019-318091 · Cited by 15
Billmeyer, K. N., Ross, J. K., Hirsch, E. B., Evans, M. D., Kline, S. E., & Galdys, A. L. (2023) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361231179668 · Cited by 15
Krey, S. C., Waise, J., & Skrupky, L. P. (2017) · Journal of Pharmacy Practice · doi:10.1177/0897190017743154 · Cited by 15
Puthran, S., Ramasubramanian, V., Murlidharan, P., Nambi, S., Pavithra, S., & Petigara, T. (2018) · Indian Journal of Nephrology · doi:10.4103/ijn.ijn_207_17 · Cited by 15
Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study
Ortiz-Álvarez, A., Delgado-Ramírez, M. A., Cuevas-Zuñiga, M., Hernández-Carrera, T., Barrón, D. M., Zapata, D. A., Vázquez, R. R. V., Ramírez-Hinojosa, J. P., & Rodríguez‐Zulueta, P. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173468 · Cited by 15
Gil-Navarro, M. V., Márquez, R. L., Gutiérrez, N. B., Álvarez‐Marín, R., Navarro-Amuedo, M. D., Praena‐Segovia, J., Carmona-Caballero, J. M., Fraile-Ramos, E., & López-Cortés, L. E. (2020) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2020.01.019 · Cited by 15
Evaluation of Outpatient Parenteral Antimicrobial Therapy at a Veterans Affairs Hospital
Spivak, E. S., Kendall, B., Orlando, P. L., Perez, C., Amorim, M. D., Samore, M. H., Pavia, A. T., & Hersh, A. L. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.131 · Cited by 15
Wijnakker, R., Visser, L. E., Schippers, E. F., Visser, L. G., van Burgel, N. D., & van Nieuwkoop, C. (2018) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-018-0751-4 · Cited by 15
Tratamiento antibiótico parenteral en el paciente ambulatorio
Garde, C., & Goenaga, M. Á. (2005) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13078796 · Cited by 15
Wolie, Z. T., Roberts, J. A., López-Cortés, L. E., Mirón-Rubio, M., Pollard, J., Nor, A. N. M., Abdul-Aziz, M. H., Jamieson, C., Seaton, R. A., Gilchrist, M. J., et al. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf075 · Cited by 14
Metadata
- Authors
- Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N.
- Affiliations
- University of Hawaiʻi at Mānoa (US)
- Cleveland Clinic (US)
- Ochsner Medical Center (US)
- Rady Children's Hospital-San Diego (US)
- Consultants in Infectious Diseases, Lubbock, Texas
- Springfield Clinic (US)
- Morgantown Internal Medicine Group, Morgantown, West Virginia
- Pfizer (United States) (US)
- Florida Infection Physicians, Gainsville
- Hennepin County Medical Center (US)
- Corresponding author
- Tice, Alan D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06-15
- Volume
- 38
- Issue
- 12
- Pages
- 1651-1671
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2141994303
- Cited by
- 532
- References
- 239
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 18 · 2023: 17 · 2022: 21 · 2021: 21 · 2020: 31 · 2019: 38 · 2018: 48 · 2017: 40 · 2016: 43 · 2015: 32 · 2014: 36 · 2013: 31 · 2012: 21
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- outpatient parenteral antimicrobial therapy, outpatient antibiotic therapy, patient selection, antimicrobial selection, once-daily dosing, drug stability, laboratory monitoring, adverse drug reactions, quality of care, multidisciplinary team
- MeSH terms
- Adult, Anti-Bacterial Agents, Child, Home Care Services, Humans, Infusions, Intravenous, Outpatients, Patient Care Team, Pediatrics, Drug Monitoring, Outcome Assessment, Health Care, Patient Selection, Home Infusion Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.